olaparib + abiraterone

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

olaparib + abiraterone

Aug 10, 2024, 14:33 | Insight

Importance of early genetic testing for prostate cancer patients

Kenrick Ng, Consultant in Medical Oncology at Barts Health NHS Trust, shared on X about…

Jan 31, 2024, 18:28 | Drugs

Day 1 of GU24 ASCO Highlights by Oncology Brothers

Oncology Brothers shared on their X/Twitter page: "Day 1 GU24 ASCO Highlights 1. CONTAC02: Atezo/Cabo…

Dec 29, 2023, 05:18 | Blog

U.S. FDA summarizes their decision to restrict the approval of olaparib + abiraterone - American Society of Clinical Oncology (ASCO)

American Society of Clinical Oncology (ASCO) shared on their X/Twitter page: ''Breaking from Journal of…

All: 3 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023